venetoclax,gilteritinib
abbvie,roche,astellas
['venetoclax', 'gilteritinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'leusm']
#ash22 #leusm gangat: tp53 enriched in refractory while asxl1 enriched in relapsed. only 15% proceeded to 2nd line therapy (surprising ) and only 1 was transplanted. no diff in os in refractory vs relapsed. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)